Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Eton Pharmaceuticals, Inc. (ETON)
USD38.12
+0.61 (+1.61%)
US NASDAQ Healthcare Drug Manufacturers - Specialty & Generic
Address
21925 W. Field Parkway 60010-7278
Deer Park, IL, US
Deer Park, IL, US
CEO
Sean E. Brynjelsen
Website
etonpharma.com
IPO
2018-11-14
CIK 1710340 ISIN US29772L1089
Description
Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 for Wilson disease; ET-800 for adrenal insufficiency; and ZENEO hydrocortisone autoinjector for adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD38.12
+0.61 (+1.61%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
410.7K
Beta
0.89
Float Shares
23.21M
Free Float %
84.8%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.79% | -3.14% | +10.47% | +75.51% | +76.86% | +77.17% | +75.00% | +746.33% | +263.15% | +379.36% | +379.36% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (6 ratings, all time)
Buy
Price Targets & DCF
Current price
38.12
Low
15.00
-60.6%
Consensus
25.00
-34.4%
Median
25.00
-34.4%
High
35.00
-8.2%
DCF (Levered)
3.11
-91.8%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 3 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | 1 |
35.00
-8.2%
|
| All Time | 5 |
15.60
-59.1%
|
Quality scores
Altman Z-Score
6.83
Safe zone
Piotroski F-Score
4 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
3 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Drug Manufacturers - Specialty & Generic: +6.8%+104.9% ★ Q1'26: +40.4% (vs Q1'25)
-
EPS growth Drug Manufacturers - Specialty & Generic: +16.5%-13.3% Q1'26: +185.5% (vs Q1'25)
-
FCF margin FCF growth · Drug Manufacturers - Specialty & Generic: +32.3%-2.4% Q1'26: +30.2% (vs Q1'25)
-
EBIT margin Drug Manufacturers - Specialty & Generic: +13.0%+0.1% Q1'26: +0.0% (vs Q1'25)
-
ROIC Drug Manufacturers - Specialty & Generic: +6.5%+0.2% Q1'26: +0.0% (vs Q1'25)
-
Share dilution Drug Manufacturers - Specialty & Generic: +0.0%+3.9% Q1'26: +17.3% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Drug Manufacturers - Specialty & Generic: -0.10×7.54× Q1'26: 1.27× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 2 EPS Ana. |
Dec 2027 2 Rev. Ana. 2 EPS Ana. |
Dec 2028 3 Rev. Ana. 3 EPS Ana. |
Dec 2029 2 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
959.0K
est: 1.17M (-18.1%)
|
39.0K
est: 1.16M (-96.6%)
|
21.83M
est: 23.30M (-6.3%)
|
21.25M
est: 21.80M (-2.5%)
|
31.64M
est: 31.38M (+0.8%)
|
39.01M
est: 37.91M (+2.9%)
|
79.95M
est: 79.27M (+0.9%)
|
108.36M
108.27M – 108.44M
+36.7% YoY
|
172.10M
163.72M – 180.47M
+58.8% YoY
|
230.54M
229.75M – 231.33M
+34.0% YoY
|
319.11M
306.74M – 331.08M
+38.4% YoY
|
405.98M
390.24M – 421.21M
+27.2% YoY
|
| EBITDA |
-18.15M
est: -327.4K (-5,444.2%)
|
-26.46M
est: -324.8K (-8,045.8%)
|
-1.03M
est: -6.52M (+84.2%)
|
-6.49M
est: -6.10M (-6.3%)
|
-291.0K
est: -2.18M (+86.7%)
|
-1.45M
est: -2.63M (+44.9%)
|
4.12M
est: -5.51M (+174.7%)
|
-7.53M
-7.54M – -7.52M
-36.7% YoY
|
-11.96M
-12.54M – -11.38M
-58.8% YoY
|
-16.02M
-16.07M – -15.96M
-34.0% YoY
|
-22.17M
-23.01M – -21.31M
-38.4% YoY
|
-28.21M
-29.27M – -27.12M
-27.2% YoY
|
| EBIT |
-18.60M
est: -365.5K (-4,989.6%)
|
-27.11M
est: -362.6K (-7,377.7%)
|
-1.50M
est: -7.28M (+79.5%)
|
-8.26M
est: -6.81M (-21.3%)
|
-1.19M
est: -3.52M (+66.1%)
|
-2.60M
est: -4.25M (+38.9%)
|
72.0K
est: -8.89M (+100.8%)
|
-12.15M
-12.16M – -12.14M
-36.7% YoY
|
-19.29M
-20.23M – -18.35M
-58.8% YoY
|
-25.84M
-25.93M – -25.76M
-34.0% YoY
|
-35.77M
-37.11M – -34.39M
-38.4% YoY
|
-45.51M
-47.22M – -43.75M
-27.2% YoY
|
| Net Income |
-18.32M
est: -29.69M (+38.3%)
|
-27.97M
est: -33.02M (+15.3%)
|
-1.96M
est: -2.07M (+5.6%)
|
-9.02M
est: -9.87M (+8.6%)
|
-936.0K
est: -6.69M (+86.0%)
|
-3.82M
est: -4.13M (+7.4%)
|
-4.60M
est: 9.96M (-146.2%)
|
26.13M
16.44M – 28.76M
+162.5% YoY
|
54.09M
41.82M – 57.29M
+107.0% YoY
|
78.88M
60.09M – 91.80M
+45.8% YoY
|
117.32M
111.41M – 123.04M
+48.7% YoY
|
157.82M
149.87M – 165.51M
+34.5% YoY
|
| SGA |
7.55M
est: 77.22M (-90.2%)
|
12.76M
est: 76.60M (-83.3%)
|
14.47M
est: 1.54B (-99.1%)
|
18.58M
est: 1.44B (-98.7%)
|
18.93M
est: 19.87M (-4.7%)
|
22.75M
est: 24.01M (-5.2%)
|
35.82M
est: 50.20M (-28.7%)
|
68.63M
68.57M – 68.68M
+36.7% YoY
|
108.99M
103.69M – 114.30M
+58.8% YoY
|
146.01M
145.51M – 146.51M
+34.0% YoY
|
202.10M
194.27M – 209.69M
+38.4% YoY
|
257.12M
247.16M – 266.77M
+27.2% YoY
|
| EPS |
-1.02
est: -1.15 (+11.0%)
|
-1.33
est: -1.28 (-4.3%)
|
-0.08
est: -0.08 (+3.0%)
|
-0.36
est: -0.38 (+5.3%)
|
-0.04
est: -0.26 (+85.9%)
|
-0.15
est: -0.13 (-18.4%)
|
-0.17
est: 0.37 (-145.9%)
|
0.85
0.61 – 1.07
+128.4% YoY
|
1.85
1.55 – 2.13
+118.5% YoY
|
2.75
2.23 – 3.41
+48.9% YoY
|
4.36
4.14 – 4.57
+58.5% YoY
|
5.87
5.57 – 6.15
+34.5% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-14 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-13 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-12 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-11 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-08 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-07 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-06 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-05 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-01 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
5.65M
OE per share TTM
0.17
Owner's Yield
0.69%
Maintenance CapEx ratio
3.84%
Maint CapEx / Avg PPE
1.9%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
52
Total invested
88.27M
Insider transactions (90d)
1
Beneficial owners (>5%)
17
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Private Capital Management, LLC (46-3167283) | 3.63M | 10.34% | 2.08M | 1.55M | 2.08M | 1.55M | IA | Delaware | 2024-01-09 | ↗ |
| 2 | Imprimis Pharmaceuticals, Inc. | 3.50M | 20.70% | 3.50M | — | 3.50M | — | CO | State of Delaware | 2018-11-23 | ↗ |
| 3 | 20-5648796 | 2.39M | 9.69% | — | — | 13.00 | 2.39M | CO | Massachusetts | 2022-01-24 | ↗ |
| 4 | The Vanguard Group - 23-1945930 | 1.81M | 5.15% | — | 54.8K | 1.73M | 79.6K | IA | Pennsylvania | 2024-02-13 | ↗ |
| 5 | EcoR1 Capital, LLC | 1.40M | 11.00% | — | 1.40M | — | — | IA, OO | Delaware | 2024-12-09 | ↗ |
| 6 | Oleg Nodelman | 1.40M | 11.00% | — | 1.40M | — | — | HC, IN | Delaware | 2024-12-09 | ↗ |
| 7 | Brynjelsen | 1.37M | 7.60% | 1.37M | — | 1.37M | — | IN | United States of America | 2020-02-04 | ↗ |
| 8 | EcoR1 Capital Fund Qualified, L.P. | 1.32M | 11.00% | — | — | — | — | PN | Delaware | 2024-12-09 | ↗ |
| 9 | 13-3127734 | 1.20M | 4.46% | 1.12M | — | 1.20M | — | HC | Delaware | 2022-02-10 | ↗ |
| 10 | 26-0385758 | 1.20M | 4.46% | 1.12M | — | 1.20M | — | IA | Delaware | 2022-02-10 | ↗ |
| 11 | Peter A. Appel | 1.08M | 4.48% | 1.08M | — | 1.08M | — | IN | United States | 2021-02-16 | ↗ |
| 12 | Marathon Asset Management, L.P. | 833.3K | 4.50% | 833.3K | — | 833.3K | — | IA | Delaware United States | 2017-02-14 | ↗ |
| 13 | BARCLAYS GLOBAL INVESTORS, NA. | 771.1K | 6.66% | — | 1.08M | — | 1.08M | BK | Massachusetts | 2018-09-07 | ↗ |
| 14 | Ophir Global Opportunities Fund | 768.9K | 2.80% | 768.9K | — | 768.9K | — | OO | Australia | 2024-10-08 | ↗ |
| 15 | Kevin R. Hanson | 200.0K | 0.05% | 5.00 | — | — | — | IN | Massachusetts | 2021-06-17 | ↗ |
| 16 | 1 | 9.00 | 11.00% | — | 881.7K | — | 881.7K | IN | Massachusetts | 2019-05-24 | ↗ |
| 17 | Opaleye Management Inc. | 9.00 | 11.00% | — | 881.7K | — | 881.7K | CO | Massachusetts | 2019-05-24 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
52
-52 vs prev Q
New positions
12
Closed positions
64
Increased
27
Reduced
15
Put/Call ratio
0.83
Calls held
20.8K
Puts held
17.3K
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | OPALEYE MANAGEMENT INC. | 2.86M +— (+0.0%) | 48.36M -13.8M (-22.2%) | 10.63% +0.000 pp | 6.38% -2.406 pp | USD5.51 +206.9% | 29 qtrs — |
| 2 | ECOR1 CAPITAL, LLC | 2.03M +— (+0.0%) | 34.34M -9.8M (-22.2%) | 7.55% +0.000 pp | 1.56% -0.560 pp | USD11.30 +49.6% | 6 qtrs — |
| 3 | BLACKROCK, INC. | 1.74M +34.5K (+2.0%) | 29.40M -7.6M (-20.6%) | 6.47% +0.129 pp | 0.00% 0.000 pp | USD13.66 +23.8% | 6 qtrs — |
| 4 | VANGUARD GROUP INC | 1.35M +4.6K (+0.3%) | 22.81M -6.4M (-21.9%) | 5.01% +0.017 pp | 0.00% 0.000 pp | USD8.48 +99.4% | 28 qtrs — |
| 5 | NANTAHALA CAPITAL MANAGEMENT, LLC | 1.18M +— (+0.0%) | 19.89M -5.7M (-22.2%) | 4.37% +0.000 pp | 0.66% -0.230 pp | USD5.01 +237.5% | 7 qtrs — |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 565.1K -9.0K (-1.6%) | 9.56M -2.9M (-23.4%) | 2.10% -0.033 pp | 0.00% 0.000 pp | USD10.39 +62.8% | 23 qtrs — |
| 7 | STATE STREET CORP | 501.9K +63.5K (+14.5%) | 8.49M -1.0M (-10.9%) | 1.87% +0.236 pp | 0.00% +0.000 pp | USD14.91 +13.4% | 23 qtrs — |
| 8 | MORGAN STANLEY | 493.9K -92.1K (-15.7%) | 8.35M -4.4M (-34.4%) | 1.84% -0.343 pp | 0.00% 0.000 pp | USD14.91 +13.4% | 29 qtrs — |
| 9 | WESTSIDE INVESTMENT MANAGEMENT, INC. | 470.9K -1.6K (-0.3%) | 7.96M -2.3M (-22.4%) | 1.75% -0.006 pp | 1.27% -0.367 pp | USD3.62 +367.1% | 24 qtrs — |
| 10 | OBERWEIS ASSET MANAGEMENT INC/ | 431.3K +238.9K (+124.2%) | 7.29M +3.1M (+74.5%) | 1.60% +0.889 pp | 0.27% +0.107 pp | USD19.06 -11.3% | 2 qtrs — |
| 11 | THOMPSON SIEGEL & WALMSLEY LLC | 408.5K -10.0K (-2.4%) | 6.91M -2.2M (-24.0%) | 1.52% -0.037 pp | 0.12% -0.031 pp | USD11.72 +44.3% | 7 qtrs — |
| 12 | BNP PARIBAS ARBITRAGE, SNC | 277.5K +47.7K (+20.7%) | 4.69M -301.5K (-6.0%) | 1.03% +0.177 pp | 0.00% -0.001 pp | USD18.35 -7.8% | 23 qtrs — |
| 13 | NORTHERN TRUST CORP | 231.8K -13.2K (-5.4%) | 3.92M -1.4M (-26.4%) | 0.86% -0.049 pp | 0.00% 0.000 pp | USD12.15 +39.2% | 26 qtrs — |
| 14 | CANNELL CAPITAL LLC | 216.9K -238.5K (-52.4%) | 3.67M -6.2M (-62.9%) | 0.81% -0.887 pp | 1.78% +0.270 pp | USD14.43 +17.2% | 5 qtrs — |
| 15 | RENAISSANCE TECHNOLOGIES LLC | 205.7K -118.9K (-36.6%) | 3.48M -3.6M (-50.7%) | 0.76% -0.442 pp | 0.01% -0.004 pp | USD11.57 +46.2% | 12 qtrs — |
| 16 | GOLDMAN SACHS GROUP INC | 196.3K +6.1K (+3.2%) | 3.32M -813.5K (-19.7%) | 0.73% +0.023 pp | 0.00% 0.000 pp | USD16.84 +0.4% | 10 qtrs — |
| 17 | DIAMETRIC CAPITAL, LP | 193.2K +93.8K (+94.5%) | 3.27M +1.1M (+51.4%) | 0.72% +0.349 pp | 0.88% +0.075 pp | USD15.97 +5.9% | 4 qtrs — |
| 18 | JPMORGAN CHASE & CO | 185.4K -166.0K (-47.2%) | 3.14M -4.5M (-58.9%) | 0.69% -0.617 pp | 0.00% 0.000 pp | USD16.19 +4.4% | 8 qtrs — |
| 19 | LUMBARD & KELLNER, LLC | 174.9K -1.4K (-0.8%) | 2.96M -872.7K (-22.8%) | 0.65% -0.005 pp | 1.04% -0.373 pp | USD21.73 -22.2% | 2 qtrs — |
| 20 | ARISTIDES CAPITAL LLC | 161.4K -6.2K (-3.7%) | 2.73M -911.8K (-25.0%) | 0.60% -0.023 pp | 0.48% -0.042 pp | USD5.11 +230.9% | 7 qtrs — |
| 21 | BANK OF NEW YORK MELLON CORP | 127.7K -1.5K (-1.1%) | 2.16M -647.7K (-23.1%) | 0.47% -0.006 pp | 0.00% 0.000 pp | USD9.16 +84.6% | 23 qtrs — |
| 22 | UBS GROUP AG | 126.7K -93.7K (-42.5%) | 2.14M -2.6M (-55.3%) | 0.47% -0.348 pp | 0.00% 0.000 pp | USD13.58 +24.5% | 28 qtrs — |
| 23 | JEFFERIES FINANCIAL GROUP INC. | 118.3K +29.9K (+33.8%) | 2.00M +78.7K (+4.1%) | 0.44% +0.111 pp | 0.01% +0.001 pp | USD20.51 -17.6% | 5 qtrs — |
| 24 | BANK OF AMERICA CORP /DE/ | 104.8K +30.1K (+40.4%) | 1.77M +149.8K (+9.2%) | 0.39% +0.112 pp | 0.00% +0.000 pp | USD17.58 -3.8% | 9 qtrs — |
| 25 | WOODLINE PARTNERS LP | 95.5K +95.5K (+100.0%) | 1.61M +1.6M (+100.0%) | 0.36% +0.355 pp | 0.01% +0.006 pp | USD16.91 +0.0% | 1 qtrs NEW |
| 26 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 84.0K -25.0K (-22.9%) | 1.42M -948.2K (-40.0%) | 0.31% -0.093 pp | 0.03% -0.021 pp | USD4.87 +247.2% | 20 qtrs — |
| 27 | WELLINGTON MANAGEMENT GROUP LLP | 81.2K -7.0K (-8.0%) | 1.37M -543.9K (-28.4%) | 0.30% -0.026 pp | 0.00% 0.000 pp | USD18.89 -10.5% | 4 qtrs — |
| 28 | MILLENNIUM MANAGEMENT LLC | 79.3K +63.5K (+400.1%) | 1.34M +996.8K (+289.2%) | 0.30% +0.236 pp | 0.00% +0.000 pp | USD17.87 -5.4% | 5 qtrs — |
| 29 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 77.2K -62.0 (-0.1%) | 1.31M -373.5K (-22.2%) | 0.29% 0.000 pp | 0.00% 0.000 pp | USD12.27 +37.8% | 15 qtrs — |
| 30 | TWO SIGMA INVESTMENTS, LP | 76.6K -209.8K (-73.3%) | 1.30M -4.9M (-79.2%) | 0.28% -0.780 pp | 0.00% -0.007 pp | USD15.86 +6.6% | 10 qtrs — |
| 31 | CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 76.6K -67.2K (-46.7%) | 1.30M -1.8M (-58.6%) | 0.28% -0.250 pp | 0.00% -0.006 pp | USD10.98 +54.0% | 10 qtrs — |
| 32 | CITADEL ADVISORS LLC | 74.1K +74.1K (+100.0%) | 1.25M +1.3M (+100.0%) | 0.28% +0.276 pp | 0.00% +0.000 pp | USD16.91 +0.0% | 1 qtrs NEW |
| 33 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 62.4K -30.3K (-32.7%) | 1.06M -959.2K (-47.6%) | 0.23% -0.113 pp | 0.00% 0.000 pp | USD14.25 +18.7% | 10 qtrs — |
| 34 | NUVEEN, LLC | 58.9K +— (+0.0%) | 996.3K -284.0K (-22.2%) | 0.22% +0.000 pp | 0.00% 0.000 pp | USD14.25 +18.7% | 3 qtrs — |
| 35 | JANE STREET GROUP, LLC | 58.1K -12.9K (-18.2%) | 981.7K -559.9K (-36.3%) | 0.22% -0.048 pp | 0.00% 0.000 pp | USD21.73 -22.2% | 13 qtrs — |
| 36 | BARCLAYS PLC | 51.4K +14.6K (+39.8%) | 870.0K +70.2K (+8.8%) | 0.19% +0.054 pp | 0.00% +0.000 pp | USD14.36 +17.8% | 5 qtrs — |
| 37 | RUSSELL INVESTMENTS GROUP, LTD. | 49.7K -5.2K (-9.4%) | 840.3K -351.9K (-29.5%) | 0.18% -0.019 pp | 0.00% 0.000 pp | USD19.26 -12.2% | 3 qtrs — |
| 38 | PRELUDE CAPITAL MANAGEMENT, LLC | 45.3K +3.5K (+8.2%) | 766.4K -143.5K (-15.8%) | 0.17% +0.013 pp | 0.06% -0.015 pp | USD13.32 +27.0% | 5 qtrs — |
| 39 | ANCHOR CAPITAL ADVISORS LLC | 40.7K +3.9K (+10.6%) | 687.7K -111.5K (-14.0%) | 0.15% +0.015 pp | 0.02% -0.003 pp | USD13.93 +21.4% | 5 qtrs — |
| 40 | XTX TOPCO LTD | 32.5K +8.1K (+33.3%) | 550.0K +19.8K (+3.7%) | 0.12% +0.030 pp | 0.01% -0.013 pp | USD20.53 -17.6% | 10 qtrs — |
| 41 | BLAIR WILLIAM & CO/IL | 32.4K +— (+0.0%) | 547.9K -156.2K (-22.2%) | 0.12% +0.000 pp | 0.00% 0.000 pp | USD6.10 +177.2% | 19 qtrs — |
| 42 | RHUMBLINE ADVISERS | 30.4K -5.7K (-15.7%) | 514.7K -270.3K (-34.4%) | 0.11% -0.021 pp | 0.00% 0.000 pp | USD14.25 +18.7% | 3 qtrs — |
| 43 | WELLS FARGO & COMPANY/MN | 28.3K +11.6K (+69.3%) | 478.4K +115.3K (+31.8%) | 0.11% +0.043 pp | 0.00% +0.000 pp | USD16.10 +5.0% | 5 qtrs — |
| 44 | STATE OF WISCONSIN INVESTMENT BOARD | 24.6K +24.6K (+100.0%) | 416.2K +416.2K (+100.0%) | 0.09% +0.092 pp | 0.00% +0.001 pp | USD16.91 +0.0% | 1 qtrs NEW |
| 45 | AQUATIC CAPITAL MANAGEMENT LLC | 22.8K -13.5K (-37.2%) | 385.6K -403.9K (-51.2%) | 0.08% -0.050 pp | 0.01% -0.004 pp | USD14.35 +17.8% | 3 qtrs — |
| 46 | ESSEX INVESTMENT MANAGEMENT CO LLC | 20.2K +— (+0.0%) | 341.3K -97.3K (-22.2%) | 0.08% +0.000 pp | 0.05% -0.015 pp | USD3.76 +349.7% | 11 qtrs — |
| 47 | INVESCO LTD. | 19.7K +6.2K (+46.1%) | 333.0K +40.1K (+13.7%) | 0.07% +0.023 pp | 0.00% +0.000 pp | USD15.09 +12.1% | 3 qtrs — |
| 48 | JUNCTURE WEALTH STRATEGIES, LLC | 19.0K +2.0K (+12.0%) | 321.2K -47.5K (-12.9%) | 0.07% +0.008 pp | 0.11% -0.018 pp | USD21.22 -20.3% | 2 qtrs — |
| 49 | BRIDGE CITY CAPITAL, LLC | 18.6K +1.9K (+11.6%) | 314.5K -47.8K (-13.2%) | 0.07% +0.007 pp | 0.09% -0.004 pp | USD21.23 -20.3% | 2 qtrs — |
| 50 | DEUTSCHE BANK AG\ | 18.2K +850.0 (+4.9%) | 308.6K -69.5K (-18.4%) | 0.07% +0.003 pp | 0.00% +0.000 pp | USD14.37 +17.7% | 3 qtrs — |
| 51 | CHICAGO TRUST CO NA | 16.7K +— (+0.0%) | 282.4K -80.5K (-22.2%) | 0.06% +0.000 pp | 0.04% -0.007 pp | USD5.04 +235.5% | 18 qtrs — |
| 52 | LOS ANGELES CAPITAL MANAGEMENT LLC | 14.6K +14.6K (+100.0%) | 267.0K +267.0K (+100.0%) | 0.05% +0.054 pp | 0.00% +0.001 pp | USD16.91 +0.0% | 1 qtrs NEW |
| 53 | VOLEON CAPITAL MANAGEMENT LP | 15.6K +4.6K (+42.3%) | 263.5K +25.5K (+10.7%) | 0.06% +0.017 pp | 0.01% 0.000 pp | USD20.30 -16.7% | 2 qtrs — |
| 54 | METLIFE INVESTMENT MANAGEMENT, LLC | 15.5K +— (+0.0%) | 262.7K -74.9K (-22.2%) | 0.06% +0.000 pp | 0.00% 0.000 pp | USD14.25 +18.7% | 3 qtrs — |
| 55 | PRICE T ROWE ASSOCIATES INC /MD/ | 15.4K +1.8K (+13.6%) | 260.0K -34.0K (-11.6%) | 0.06% +0.007 pp | 0.00% +0.000 pp | USD14.90 +13.5% | 3 qtrs — |
| 56 | D. E. SHAW & CO., INC. | 15.3K +15.3K (+100.0%) | 259.2K +259.2K (+100.0%) | 0.06% +0.057 pp | 0.00% +0.000 pp | USD16.91 +0.0% | 1 qtrs NEW |
| 57 | PDT PARTNERS, LLC | 14.9K +— (+0.0%) | 251.8K -71.8K (-22.2%) | 0.06% +0.000 pp | 0.02% -0.004 pp | USD12.98 +30.3% | 4 qtrs — |
| 58 | TWO SIGMA ADVISERS, LP | 14.7K -154.2K (-91.3%) | 248.6K -3.4M (-93.2%) | 0.05% -0.573 pp | 0.00% -0.007 pp | USD16.96 -0.3% | 5 qtrs — |
| 59 | SQUAREPOINT OPS LLC | 13.5K -46.2K (-77.4%) | 228.0K -1.1M (-82.4%) | 0.05% -0.172 pp | 0.00% -0.001 pp | USD13.37 +26.5% | 4 qtrs — |
| 60 | POINT72 ASSET MANAGEMENT, L.P. | 12.9K +12.9K (+100.0%) | 218.6K +218.6K (+100.0%) | 0.05% +0.048 pp | 0.00% +0.000 pp | USD16.91 +0.0% | 1 qtrs NEW |
| 61 | CANADA PENSION PLAN INVESTMENT BOARD | 12.5K +12.5K (+100.0%) | 211.4K +211.4K (+100.0%) | 0.05% +0.047 pp | 0.00% +0.000 pp | USD16.91 +0.0% | 1 qtrs NEW |
| 62 | INTECH INVESTMENT MANAGEMENT LLC | 12.4K +1.2K (+11.1%) | 210.0K -32.8K (-13.5%) | 0.05% +0.005 pp | 0.00% 0.000 pp | USD14.52 +16.5% | 3 qtrs — |
| 63 | RAYMOND JAMES FINANCIAL INC | 12.3K -74.8K (-85.9%) | 207.1K -1.7M (-89.1%) | 0.05% -0.278 pp | 0.00% -0.001 pp | USD13.19 +28.2% | 5 qtrs — |
| 64 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 11.9K -143.0 (-1.2%) | 200.6K -60.3K (-23.1%) | 0.04% -0.001 pp | 0.00% 0.000 pp | USD14.25 +18.7% | 3 qtrs — |
| 65 | QUANTUM PRIVATE WEALTH, LLC | 11.5K +— (+0.0%) | 194.5K -55.4K (-22.2%) | 0.04% +0.000 pp | 0.06% -0.016 pp | USD2.62 +545.4% | 15 qtrs — |
| 66 | ENVESTNET ASSET MANAGEMENT INC | 10.9K -433.0 (-3.8%) | 185.1K -62.2K (-25.1%) | 0.04% -0.002 pp | 0.00% +0.000 pp | USD13.55 +24.8% | 5 qtrs — |
| 67 | JUMP FINANCIAL, LLC | 10.6K +10.6K (+100.0%) | 178.4K +178.4K (+100.0%) | 0.04% +0.039 pp | 0.00% +0.002 pp | USD16.91 +0.0% | 1 qtrs NEW |
| 68 | MAN GROUP PLC | 10.5K -2.2K (-17.2%) | 177.1K -97.8K (-35.6%) | 0.04% -0.008 pp | 0.00% 0.000 pp | USD13.05 +29.6% | 4 qtrs — |
| 69 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 10.0K +— (+0.0%) | 169.1K -48.2K (-22.2%) | 0.04% +0.000 pp | 0.00% +0.000 pp | USD14.25 +18.7% | 3 qtrs — |
| 70 | QUANTBOT TECHNOLOGIES LP | 9.4K -2.2K (-18.9%) | 158.2K -92.4K (-36.9%) | 0.03% -0.008 pp | 0.01% -0.002 pp | USD13.86 +22.0% | 4 qtrs — |
| 71 | STATE OF WYOMING | 8.2K +2.7K (+50.0%) | 138.0K +19.8K (+16.7%) | 0.03% +0.010 pp | 0.02% +0.002 pp | USD14.29 +18.3% | 4 qtrs — |
| 72 | NEW YORK STATE COMMON RETIREMENT FUND | 8.1K +— (+0.0%) | 137.0K -39.0K (-22.2%) | 0.03% +0.000 pp | 0.00% +0.000 pp | USD14.25 +18.7% | 3 qtrs — |
| 73 | POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY | 7.2K +— (+0.0%) | 121.9K -34.7K (-22.2%) | 0.03% +0.000 pp | 0.00% 0.000 pp | USD15.36 +10.1% | 3 qtrs — |
| 74 | STATE OF ALASKA, DEPARTMENT OF REVENUE | 6.9K +5.5K (+388.6%) | 117.0K +87.0K (+290.0%) | 0.03% +0.021 pp | 0.00% +0.001 pp | USD17.90 -5.5% | 2 qtrs — |
| 75 | SG AMERICAS SECURITIES, LLC | 6.5K +6.5K (+100.0%) | 109.0K +109.0K (+100.0%) | 0.02% +0.024 pp | 0.00% +0.000 pp | USD16.91 +0.0% | 1 qtrs NEW |
| 76 | CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 4.4K +4.4K (+100.0%) | 73.9K +73.9K (+100.0%) | 0.02% +0.016 pp | 0.01% +0.006 pp | USD16.91 +0.0% | 1 qtrs NEW |
| 77 | QUEST PARTNERS LLC | 4.1K -1.0 (0.0%) | 70.2K -20.0K (-22.2%) | 0.02% +0.000 pp | 0.00% -0.002 pp | USD13.37 +26.5% | 4 qtrs — |
| 78 | FMR LLC | 3.1K -2.6K (-46.0%) | 52.0K -71.7K (-58.0%) | 0.01% -0.010 pp | 0.00% +0.000 pp | USD21.13 -20.0% | 4 qtrs — |
| 79 | TOWER RESEARCH CAPITAL LLC (TRC) | 3.0K +2.0K (+208.3%) | 50.6K +29.5K (+139.9%) | 0.01% +0.008 pp | 0.00% +0.001 pp | USD15.75 +7.4% | 23 qtrs — |
| 80 | CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 2.9K +2.9K (+100.0%) | 49.7K +49.7K (+100.0%) | 0.01% +0.011 pp | 0.01% +0.012 pp | USD16.91 +0.0% | 4 qtrs — |
| 81 | LEGAL & GENERAL GROUP PLC | 2.7K -121.0 (-4.2%) | 46.2K -15.8K (-25.5%) | 0.01% 0.000 pp | 0.00% +0.000 pp | USD14.25 +18.7% | 3 qtrs — |
| 82 | AMERITAS INVESTMENT PARTNERS, INC. | 2.2K +— (+0.0%) | 36.6K -10.4K (-22.2%) | 0.01% +0.000 pp | 0.00% 0.000 pp | USD14.25 +18.7% | 3 qtrs — |
| 83 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 1.6K -23.0 (-1.4%) | 26.7K -8.1K (-23.3%) | 0.01% 0.000 pp | 0.00% +0.000 pp | USD14.25 +18.7% | 3 qtrs — |
| 84 | CITIGROUP INC | 1.5K +240.0 (+19.8%) | 24.5K -1.8K (-6.8%) | 0.01% +0.001 pp | 0.00% +0.000 pp | USD14.69 +15.1% | 6 qtrs — |
| 85 | MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 1.3K +1.3K (+100.0%) | 22.0K +22.0K (+100.0%) | 0.00% +0.005 pp | 0.00% +0.000 pp | USD16.91 +0.0% | 1 qtrs NEW |
| 86 | TRUVESTMENTS CAPITAL LLC | 1.2K +— (+0.0%) | 20.0K -5.7K (-22.2%) | 0.00% +0.000 pp | 0.00% -0.001 pp | USD6.00 +181.8% | 12 qtrs — |
| 87 | ROYAL BANK OF CANADA | 1.0K -478.2K (-99.8%) | 17.0K -10.4M (-99.8%) | 0.00% -1.778 pp | 0.00% -0.002 pp | USD21.64 -21.9% | 12 qtrs — |
| 88 | AMALGAMATED BANK | 805.00 -71.0 (-8.1%) | 14.0K -5.0K (-26.3%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD14.25 +18.7% | 3 qtrs — |
| 89 | GF FUND MANAGEMENT CO. LTD. | 527.00 +527.0 (+100.0%) | 8.9K +8.9K (+100.0%) | 0.00% +0.002 pp | 0.00% +0.000 pp | USD16.91 +0.0% | 1 qtrs NEW |
| 90 | GROUP ONE TRADING, L.P. | 500.00 -262.0 (-34.4%) | 8.5K -8.1K (-48.9%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD21.73 -22.2% | 6 qtrs — |
| 91 | JONES FINANCIAL COMPANIES LLLP | 221.00 +221.0 (+100.0%) | 3.7K +3.7K (+100.0%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD16.91 +0.0% | 1 qtrs NEW |
| 92 | ADVISOR GROUP HOLDINGS, INC. | 200.00 +— (+0.0%) | 3.4K -964.0 (-22.2%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD14.25 +18.7% | 7 qtrs — |
| 93 | STERLING CAPITAL MANAGEMENT LLC | 167.00 +105.0 (+169.4%) | 2.8K +1.5K (+109.7%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD15.92 +6.2% | 3 qtrs — |
| 94 | VERMILLION & WHITE WEALTH MANAGEMENT GROUP, LLC | 150.00 +— (+0.0%) | 2.5K -723.0 (-22.2%) | 0.00% +0.000 pp | 0.00% -0.001 pp | USD14.25 +18.7% | 3 qtrs — |
| 95 | FARTHER FINANCE ADVISORS, LLC | 146.00 +146.0 (+100.0%) | 2.5K +2.5K (+100.0%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD16.90 +0.1% | 1 qtrs NEW |
| 96 | DAIWA SECURITIES GROUP INC. | 89.00 +89.0 (+100.0%) | 2.0K +2.0K (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD16.90 +0.1% | 1 qtrs NEW |
| 97 | US BANCORP \DE\ | 54.00 +54.0 (+100.0%) | 913.00 +913.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD16.91 +0.0% | 1 qtrs NEW |
| 98 | PNC FINANCIAL SERVICES GROUP, INC. | 51.00 +34.0 (+200.0%) | 862.00 +493.0 (+133.6%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD18.49 -8.5% | 2 qtrs — |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 68 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P Pharmaceuticals ETF XPH | 1.28% | 6.02M | 0.35% |
| 2 | First Trust Active Factor Small Cap ETF AFSM | 0.62% | 697.7K | 0.75% |
| 3 | Direxion Daily Pharmaceutical & Medical Bull 3X ETF PILL | 0.27% | 61.9K | 1.22% |
| 4 | Invesco Russell 2000 Dynamic Multifactor ETF OMFS | 0.23% | 640.0K | 0.39% |
| 5 | iShares Micro-Cap ETF IWC | 0.22% | 3.29M | 0.60% |
| 6 | American Century Small Cap Growth Insights ETF ACSG | 0.19% | 48.8K | 0.49% |
| 7 | Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF GSSC | 0.13% | 1.32M | 0.20% |
| 8 | iShares Nasdaq US Biotechnology UCITS ETF BTEE.L | 0.07% | 51.3K | 0.35% |
| 9 | iShares Nasdaq US Biotechnology UCITS ETF BTEC.L | 0.07% | 766.1K | 0.35% |
| 10 | Invesco NASDAQ Biotech UCITS ETF SBIO.L | 0.07% | 319.3K | 0.40% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
1.00
Neutral
Ratio by volume
1.00
Neutral
Buys
2
Sells
2
Shares acquired
32.2K
Shares disposed
32.2K
Cash buys
—
Cash sales
—
Net activity
+0
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-21 | RIEDEL NORBERT G | Director | M-Exempt | A | Common Stock | 19,655 | 8.61 | 169.2K | 67,155 | D | ↗ |
| 2026-02-03 | RIEDEL NORBERT G | Director | X-InTheMoney | A | Common Stock | 30,000 | 4.42 | 132.6K | 35,000 | D | ↗ |
| 2026-01-14 | Krempa David | Officer | F-InKind | D | Common Stock | 1,942 | 15.62 | 30.3K | 630,238 | D | ↗ |
| 2026-01-14 | Gruber James R. | Officer | F-InKind | D | Common Stock | 2,293 | 15.47 | 35.5K | 213,420 | D | ↗ |
| 2026-01-12 | RIEDEL NORBERT G | Director | A-Award | A | Employee Stock Option (Right to Buy) | 12,196 | 15.47 | 188.7K | 286,496 | D | ↗ |
| 2026-01-12 | MAIER PAUL V | Director | A-Award | A | Employee Stock Option (Right to Buy) | 12,196 | 15.47 | 188.7K | 286,496 | D | ↗ |
| 2026-01-12 | Krempa David | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 40,655 | 15.47 | 628.9K | 670,893 | D | ↗ |
| 2026-01-12 | Gruber James R. | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 40,655 | 15.47 | 628.9K | 254,075 | D | ↗ |
| 2026-01-12 | Erdogan-Trinkaus Ipek | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 40,655 | 15.47 | 628.9K | 123,878 | D | ↗ |
| 2026-01-12 | CASAMENTO CHARLES J | Director | A-Award | A | Employee Stock Option (Right to Buy) | 12,196 | 15.47 | 188.7K | 295,171 | D | ↗ |
| 2026-01-12 | BRYNJELSEN SEAN | Director / Officer / 10% Owner | A-Award | A | Employee Stock Option (Right to Buy) | 158,046 | 15.47 | 2.44M | 3,047,312 | D | ↗ |
| 2026-01-12 | Adams Jennifer McKie | Director | A-Award | A | Employee Stock Option (Right to Buy) | 12,196 | 15.47 | 188.7K | 170,329 | D | ↗ |
| 2026-01-01 | BRYNJELSEN SEAN | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 5,015 | 15.39 | 77.2K | 2,889,266 | D | ↗ |
| 2025-12-12 | Krempa David | Officer | F-InKind | D | Common Stock | 6,264 | 17.00 | 106.5K | 632,180 | D | ↗ |
| 2025-12-12 | Gruber James R. | Officer | F-InKind | D | Common Stock | 4,542 | 16.99 | 77.2K | 215,713 | D | ↗ |
| 2025-12-12 | Erdogan-Trinkaus Ipek | Officer | F-InKind | D | Common Stock | 85 | 16.90 | 1.4K | 2,403 | D | ↗ |
| 2025-12-12 | BRYNJELSEN SEAN | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 6,732 | 16.83 | 113.3K | 2,894,281 | D | ↗ |
| 2025-12-11 | Krempa David | Officer | A-Award | A | Restricted Stock Units | 5,300 | 0.00 | — | 638,468 | D | ↗ |
| 2025-12-11 | Gruber James R. | Officer | A-Award | A | Restricted Stock Units | 5,502 | 0.00 | — | 210,255 | D | ↗ |
| 2025-08-20 | Gruber James R. | Officer | S-Sale | D | Common Stock | 2,631 | 16.02 | 42.1K | 204,753 | D | ↗ |
| 2025-08-19 | Gruber James R. | Officer | S-Sale | D | Common Stock | 39,082 | 16.16 | 631.6K | 205,299 | D | ↗ |
| 2025-06-16 | Krempa David | Officer | S-Sale | D | Common Stock | 10,223 | 14.73 | 150.6K | 612,646 | D | ↗ |
| 2025-06-13 | Krempa David | Officer | S-Sale | D | Common Stock | 6,800 | 14.77 | 100.4K | 622,869 | D | ↗ |
| 2025-06-12 | Krempa David | Officer | S-Sale | D | Common Stock | 16,977 | 14.92 | 253.3K | 629,669 | D | ↗ |
| 2025-06-10 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 5,000 | 15.82 | 79.1K | 2,770,000 | I | ↗ |
| 2025-06-05 | BRYNJELSEN SEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 70,000 | 16.81 | 1.18M | 2,873,513 | D | ↗ |
| 2025-06-04 | BRYNJELSEN SEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 70,000 | 17.00 | 1.19M | 2,943,513 | D | ↗ |
| 2025-06-03 | BRYNJELSEN SEAN | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 400 | 19.02 | 7.6K | 3,013,513 | D | ↗ |
| 2025-01-03 | RIEDEL NORBERT G | Director | A-Award | A | Employee Stock Option (Right to Buy) | 25,000 | 13.00 | 325.0K | 25,000 | D | ↗ |
| 2025-01-03 | MAIER PAUL V | Director | A-Award | A | Employee Stock Option (Right to Buy) | 25,000 | 13.00 | 325.0K | 25,000 | D | ↗ |
| 2025-01-03 | Krempa David | Officer | A-Award | A | Restricted Stock Units | 25,876 | 0.00 | — | 25,876 | D | ↗ |
| 2025-01-03 | Gruber James R. | Officer | A-Award | A | Restricted Stock Units | 25,876 | 0.00 | — | 25,876 | D | ↗ |
| 2025-01-03 | CASAMENTO CHARLES J | Director | A-Award | A | Employee Stock Option (Right to Buy) | 25,000 | 13.00 | 325.0K | 25,000 | D | ↗ |
| 2025-01-03 | BRYNJELSEN SEAN | Director / Officer | A-Award | A | Restricted Stock Units | 72,004 | 0.00 | — | 72,004 | D | ↗ |
| 2025-01-03 | Adams Jennifer McKie | Director | A-Award | A | Employee Stock Option (Right to Buy) | 25,000 | 13.00 | 325.0K | 25,000 | D | ↗ |
| 2024-12-02 | Erdogan-Trinkaus Ipek | Officer | — | — | Employee Stock Option (Right to Buy) | 75,000 | 12.46 | 934.5K | 0 | D | ↗ |
| 2024-10-23 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 10,000 | 7.98 | 79.8K | 2,770,000 | I | ↗ |
| 2024-10-08 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 3,970 | 7.03 | 27.9K | 82,070 | I | ↗ |
| 2024-10-07 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 10,000 | 7.22 | 72.2K | 2,730,000 | I | ↗ |
| 2024-10-04 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 15,000 | 6.77 | 101.6K | 2,720,000 | I | ↗ |
| 2024-10-02 | Krempa David | Officer | A-Award | A | Restricted Stock Units | 42,088 | 0.00 | — | 861,374 | D | ↗ |
| 2024-09-11 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 45,000 | 4.75 | 213.8K | 2,705,000 | — | ↗ |
| 2024-09-10 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 50,000 | 4.65 | 232.5K | 2,660,000 | — | ↗ |
| 2024-09-09 | Opaleye Management Inc. | 10% Owner | — | I | Common Stock, par value $0.001 per share | 0 | 0.00 | — | 2,610,000 | — | ↗ |
| 2024-02-13 | RIEDEL NORBERT G | Director | A-Award | A | Stock Option (Right to buy) | 30,000 | 4.42 | 132.6K | 164,555 | — | ↗ |
| 2024-02-13 | MAIER PAUL V | Director | A-Award | A | Stock Option (Right to buy) | 30,000 | 4.42 | 132.6K | 164,555 | — | ↗ |
| 2024-02-13 | Krempa David | Officer | A-Award | A | Stock Option (Right to buy) | 144,677 | 4.42 | 639.5K | 813,430 | — | ↗ |
| 2024-02-13 | Gruber James R. | Officer | A-Award | A | Stock Option (Right to buy) | 144,677 | 4.42 | 639.5K | 374,763 | — | ↗ |
| 2024-02-13 | CASAMENTO CHARLES J | Director | A-Award | A | Stock Option (Right to buy) | 30,000 | 4.42 | 132.6K | 164,555 | — | ↗ |
| 2024-02-13 | BRYNJELSEN SEAN | Director / Officer | A-Award | A | Stock Option (Right to buy) | 438,633 | 4.42 | 1.94M | 2,473,014 | — | ↗ |
| 2024-02-13 | Adams Jennifer McKie | Director | A-Award | A | Stock Option (Right to buy) | 30,000 | 4.42 | 132.6K | 133,133 | — | ↗ |
| 2023-03-03 | RIEDEL NORBERT G | Director | A-Award | A | Stock Option (Right to buy) | 25,000 | 3.47 | 86.8K | 134,555 | — | ↗ |
| 2023-03-03 | MAIER PAUL V | Director | A-Award | A | Stock Option(Right to buy) | 25,000 | 3.47 | 86.8K | 134,555 | — | ↗ |
| 2023-03-03 | Gruber James R. | Officer | A-Award | A | Stock Option (right to buy) | 100,086 | 3.47 | 347.3K | 200,086 | — | ↗ |
| 2023-03-03 | CASAMENTO CHARLES J | Director | A-Award | A | Stock Option (Right to buy) | 25,000 | 3.47 | 86.8K | 134,555 | — | ↗ |
| 2023-03-03 | BRYNJELSEN SEAN | Director / Officer | A-Award | A | Stock Option (Right to buy) | 350,381 | 3.47 | 1.22M | 1,951,881 | — | ↗ |
| 2023-03-03 | Adams Jennifer McKie | Director | A-Award | A | Stock Option (Right to buy) | 25,000 | 3.47 | 86.8K | 103,133 | — | ↗ |
| 2023-03-01 | Krempa David | Officer | — | D | Employee Stock Option (Right to buy) | 158,270 | 3.78 | 598.3K | 0 | — | ↗ |
| 2022-09-22 | BRYNJELSEN SEAN | Director / Officer | P-Purchase | A | Common Stock | 10,000 | 2.10 | 21.0K | 1,040,000 | — | ↗ |
| 2022-07-12 | Gruber James R. | Officer | A-Award | A | Restricted Stock Units | 40,000 | 0.00 | — | 40,000 | — | ↗ |
| 2022-07-12 | BRYNJELSEN SEAN | Officer | A-Award | A | Restricted Stock Units | 110,000 | 0.00 | — | 110,000 | — | ↗ |
| 2022-04-11 | Gruber James R. | Officer | — | D | Employee Stock Options | 100,000 | 3.81 | 381.0K | 0 | — | ↗ |
| 2022-02-07 | Troutman William Wilson | Officer | A-Award | A | Stock Option (Right to buy) | 15,000 | 3.78 | 56.7K | 671,200 | — | ↗ |
| 2022-02-07 | RIEDEL NORBERT G | Director | A-Award | A | Stock Option (Right to buy) | 50,000 | 3.78 | 189.0K | 109,555 | — | ↗ |
| 2022-02-07 | MAIER PAUL V | Director | A-Award | A | Stock Option(Right to buy) | 50,000 | 3.78 | 189.0K | 109,555 | — | ↗ |
| 2022-02-07 | CASAMENTO CHARLES J | Director | A-Award | A | Stock Option (Right to buy) | 50,000 | 3.78 | 189.0K | 109,555 | — | ↗ |
| 2022-02-07 | BRYNJELSEN SEAN | Director / Officer | A-Award | A | Stock Option(Right to buy) | 416,500 | 3.78 | 1.57M | 1,601,500 | — | ↗ |
| 2022-02-07 | Adams Jennifer McKie | Director | A-Award | A | Stock Option (Right to buy) | 50,000 | 3.78 | 189.0K | 78,133 | — | ↗ |
| 2021-11-17 | Opaleye Management Inc. | 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 25,000 | 4.67 | 116.7K | 2,375,000 | — | ↗ |
| 2021-11-16 | Opaleye Management Inc. | 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 938 | 4.86 | 4.6K | 85,000 | — | ↗ |
| 2021-11-15 | Opaleye Management Inc. | 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 500 | 4.80 | 2.4K | 85,938 | — | ↗ |
| 2021-11-08 | Opaleye Management Inc. | 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 50,000 | 6.10 | 305.1K | 2,414,000 | — | ↗ |
| 2021-11-05 | Opaleye Management Inc. | 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 159,300 | 6.30 | 1.00M | 2,464,000 | — | ↗ |
| 2021-11-04 | Opaleye Management Inc. | 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 81,700 | 6.44 | 525.9K | 2,623,300 | — | ↗ |
| 2021-11-03 | Opaleye Management Inc. | 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 110,000 | 6.53 | 718.4K | 2,705,000 | — | ↗ |
| 2021-10-12 | Opaleye Management Inc. | 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 82,500 | 5.06 | 417.2K | 2,815,000 | — | ↗ |
| 2021-10-11 | Opaleye Management Inc. | 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 1,601 | 5.01 | 8.0K | 112,807 | — | ↗ |
| 2021-10-08 | Opaleye Management Inc. | 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 41,000 | 5.00 | 205.0K | 2,930,000 | — | ↗ |
| 2021-08-20 | Troutman William Wilson | Officer | P-Purchase | A | Common Stock | 5,000 | 4.43 | 22.2K | 23,027 | — | ↗ |
| 2021-08-20 | BRYNJELSEN SEAN | Director / Officer | P-Purchase | A | Common Stock | 10,000 | 4.32 | 43.2K | 1,030,000 | — | ↗ |
| 2021-08-06 | Opaleye Management Inc. | 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 330,000 | 5.84 | 1.93M | 2,971,100 | — | ↗ |
| 2021-08-05 | Opaleye Management Inc. | 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 150,000 | 5.85 | 878.0K | 3,301,100 | — | ↗ |
| 2021-08-04 | Opaleye Management Inc. | 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 100,000 | 5.75 | 575.1K | 3,451,100 | — | ↗ |
| 2021-06-15 | Opaleye Management Inc. | 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 101,000 | 8.07 | 815.1K | 3,551,100 | — | ↗ |
| 2021-06-03 | BRYNJELSEN SEAN | Director / Officer | P-Purchase | A | Common Stock | 5,000 | 5.96 | 29.8K | 1,030,000 | — | ↗ |
| 2021-05-27 | Opaleye Management Inc. | 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 121,400 | 8.49 | 1.03M | 3,652,100 | — | ↗ |
| 2021-05-26 | Opaleye Management Inc. | 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 65,500 | 8.57 | 561.3K | 3,773,500 | — | ↗ |
| 2021-05-25 | Opaleye Management Inc. | 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 46,000 | 8.53 | 392.4K | 3,839,000 | — | ↗ |
| 2021-05-03 | Troutman William Wilson | Officer | A-Award | A | Stock Option(Right to buy) | 125,000 | 8.61 | 1.08M | 656,200 | — | ↗ |
| 2021-05-03 | RIEDEL NORBERT G | Director | A-Award | A | Stock Option (Right to buy) | 19,655 | 8.61 | 169.2K | 59,555 | — | ↗ |
| 2021-05-03 | MAIER PAUL V | Director | A-Award | A | Stock Option(Right to buy) | 19,655 | 8.61 | 169.2K | 59,555 | — | ↗ |
| 2021-05-03 | CASAMENTO CHARLES J | Director | A-Award | A | Stock Option (Right to buy) | 19,655 | 8.61 | 169.2K | 59,555 | — | ↗ |
| 2021-05-03 | BRYNJELSEN SEAN | Director / Officer | A-Award | A | Stock Option(Right to buy) | 245,000 | 8.61 | 2.11M | 1,185,000 | — | ↗ |
| 2021-05-03 | Adams Jennifer McKie | Director | A-Award | A | Stock Option (Right to buy) | 28,133 | 8.61 | 242.2K | 28,133 | — | ↗ |
| 2021-04-12 | HARROW HEALTH, INC. | 10% Owner | S-Sale | D | Common Stock | 1,518,000 | 7.00 | 10.63M | 1,982,000 | — | ↗ |
| 2021-03-17 | Adams Jennifer McKie | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-12-31 | CASAMENTO CHARLES J | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-10-16 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 385,000 | 7.00 | 2.70M | 3,885,000 | — | ↗ |
| 2020-03-26 | Opaleye Management Inc. | 10% Owner | — | I | Common Stock, $0.001 par value | 0 | 0.00 | — | 3,500,000 | — | ↗ |
| 2020-03-12 | Troutman William Wilson | Officer | A-Award | A | Stock Option (Right to buy) | 186,200 | 3.58 | 666.6K | 186,200 | — | ↗ |
| 2020-03-12 | RIEDEL NORBERT G | Director | A-Award | A | Stock Option (Right to buy) | 27,400 | 3.58 | 98.1K | 27,400 | — | ↗ |
| 2020-03-12 | MAIER PAUL V | Director | A-Award | A | Stock Option (Right to buy) | 27,400 | 3.58 | 98.1K | 27,400 | — | ↗ |
| 2020-03-12 | CASAMENTO CHARLES J | Director | A-Award | A | Stock Option (Right to buy) | 27,400 | 3.58 | 98.1K | 27,400 | — | ↗ |
| 2020-03-12 | BRYNJELSEN SEAN | Director / Officer | A-Award | A | Stock Option (Right to buy) | 490,000 | 3.58 | 1.75M | 490,000 | — | ↗ |
| 2020-03-12 | BAUM MARK L | Director | A-Award | A | Stock Option (Right to buy) | 27,400 | 3.58 | 98.1K | 27,400 | — | ↗ |
| 2019-08-13 | BRYNJELSEN SEAN | Director / Officer | P-Purchase | A | Common Stock | 5,000 | 6.15 | 30.8K | 1,025,000 | — | ↗ |
| 2019-08-09 | CASAMENTO CHARLES J | Director | P-Purchase | A | Common Stock | 3,500 | 6.11 | 21.4K | 71,920 | — | ↗ |
| 2019-05-21 | BRYNJELSEN SEAN | Director / Officer | P-Purchase | A | Common Stock | 8,600 | 7.96 | 68.4K | 1,020,000 | — | ↗ |
| 2019-05-20 | BRYNJELSEN SEAN | Director / Officer | P-Purchase | A | Common Stock | 1,400 | 7.78 | 10.9K | 1,011,400 | — | ↗ |
| 2019-02-20 | Troutman William Wilson | Officer | A-Award | A | Stock option (right to buy) | 95,000 | 7.31 | 694.5K | 95,000 | — | ↗ |
| 2019-02-20 | RIEDEL NORBERT G | Director | A-Award | A | Stock option (right to buy) | 12,500 | 7.31 | 91.4K | 12,500 | — | ↗ |
| 2019-02-20 | MAIER PAUL V | Director | A-Award | A | Stock option (right to buy) | 12,500 | 7.31 | 91.4K | 12,500 | — | ↗ |
| 2019-02-20 | CASAMENTO CHARLES J | Director | A-Award | A | Stock option (right to buy) | 12,500 | 7.31 | 91.4K | 12,500 | — | ↗ |
| 2019-02-20 | BRYNJELSEN SEAN | Director / Officer | A-Award | A | Stock option (right to buy) | 250,000 | 7.31 | 1.83M | 250,000 | — | ↗ |
| 2019-02-20 | BAUM MARK L | Director | A-Award | A | Stock option (right to buy) | 12,500 | 7.31 | 91.4K | 12,500 | — | ↗ |
| 2018-11-15 | Troutman William Wilson | Officer | P-Purchase | A | Common Stock | 5,000 | 6.00 | 30.0K | 5,000 | — | ↗ |
| 2018-11-15 | RIEDEL NORBERT G | Director | P-Purchase | A | Common Stock | 5,000 | 6.00 | 30.0K | 59,745 | — | ↗ |
| 2018-11-15 | MAIER PAUL V | Director | P-Purchase | A | Common Stock | 5,000 | 6.00 | 30.0K | 59,745 | — | ↗ |
| 2018-11-15 | CASAMENTO CHARLES J | Director | C-Conversion | D | Series A Convertible Preferred Stock | 8,000 | 0.00 | — | 0 | — | ↗ |
| 2018-11-15 | BRYNJELSEN SEAN | Director / Officer | C-Conversion | A | Common Stock | 24,940 | 0.00 | — | 24,940 | — | ↗ |
| 2018-11-15 | BAUM MARK L | Director | P-Purchase | A | Common Stock | 10,000 | 6.00 | 60.0K | 10,000 | — | ↗ |
| 2018-11-09 | Troutman William Wilson | Officer | — | D | Stock Option (right to buy) | 150,000 | 1.38 | 207.0K | 0 | — | ↗ |
| 2018-11-09 | RIEDEL NORBERT G | Director | — | D | Common Stock | 0 | 0.00 | — | 54,745 | — | ↗ |
| 2018-11-09 | MAIER PAUL V | Director | — | D | Restricted Stock Units | 25,000 | 0.00 | — | 0 | — | ↗ |
| 2018-11-09 | Imprimis Pharmaceuticals, Inc. | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 3,500,000 | — | ↗ |
| 2018-11-09 | CASAMENTO CHARLES J | Director | — | D | Restricted Stock Units | 25,000 | 0.00 | — | 0 | — | ↗ |
| 2018-11-09 | BRYNJELSEN SEAN | Director / Officer | — | D | Common Stock | 0 | 0.00 | — | 1,000,000 | — | ↗ |
| 2018-11-09 | BAUM MARK L | Director | — | D | Restricted Stock Units | 25,000 | 0.00 | — | 0 | — | ↗ |
| 2017-12-08 | BRYNJELSEN SEAN | Director / Officer | — | I | Series A Convertible Preferred Stock | 23,000 | 0.00 | — | 0 | — | ↗ |
| 2017-06-20 | CASAMENTO CHARLES J | Director | — | D | Series A Convertible Preferred Stock | 8,000 | 0.00 | — | 0 | — | ↗ |
Executive team
Top executives
EBIT / Employee
1.6K
Shares Outstanding
27.36M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Sean E. Brynjelsen President and Chief Executive Officer | 712.4K | — | 936.1K | 893.7K | 354.8K | 17.5K | 2.91M | 62.78% | ↗ |
| 2 | 2025 | James R. Gruber Chief Financial Officer | 460.5K | — | 336.4K | 321.2K | 172.0K | 108.1K | 1.40M | 47.03% | ↗ |
| 3 | 2025 | David C. Krempa Chief Business Officer | 460.5K | — | 336.4K | 321.2K | 172.0K | 104.7K | 1.39M | 47.15% | ↗ |
| 4 | 2025 | Ipek Erdogan-Trinkaus Chief Commercial Officer | 402.7K | — | — | — | 150.4K | 22.2K | 575.3K | 0.00% | ↗ |
| 5 | 2024 | Sean E. Brynjelsen President and Chief Executive Officer | 615.5K | — | — | 1.30M | 487.3K | 13.8K | 2.41M | 53.70% | ↗ |
| 6 | 2024 | David C. Krempa Chief Business Officer | 397.8K | — | 250.0K | 427.2K | 236.2K | 13.8K | 1.33M | 51.11% | ↗ |
| 7 | 2024 | James R. Gruber Chief Financial Officer | 397.8K | — | — | 427.2K | 236.2K | 13.8K | 1.08M | 39.74% | ↗ |
| 8 | 2024 | Ipek Erdogan-Trinkaus Chief Commercial Officer | 33.6K | — | 100.0K | 622.1K | 19.8K | — | 775.5K | 93.12% | ↗ |
| 9 | 2023 | Sean E. Brynjelsen President and Chief Executive Officer | 591.9K | — | — | 807.6K | 334.4K | 13.2K | 1.75M | 46.23% | ↗ |
| 10 | 2023 | James R. Gruber Chief Financial Officer | 379.2K | — | — | 230.7K | 162.1K | 13.2K | 785.1K | 29.38% | ↗ |
| 11 | 2023 | David C. Krempa Chief Business Officer | 372.6K | — | — | 171.2K | 162.1K | 12.2K | 719.1K | 23.81% | ↗ |
| 12 | 2022 | Sean E. Brynjelsen President and Chief Executive Officer | 569.5K | — | 289.3K | 962.1K | 286.4K | 12.2K | 2.12M | 59.04% | ↗ |
| 13 | 2022 | David C. Krempa Chief Business Officer | 307.9K | — | 105.2K | 382.9K | 108.7K | 12.2K | 916.8K | 53.23% | ↗ |
| 14 | 2022 | James R. Gruber Chief Financial Officer | 254.6K | — | 105.2K | 248.1K | 101.1K | 3.8K | 712.8K | 49.56% | ↗ |
| 15 | 2021 | Sean E. Brynjelsen President and Chief Executive Officer | 542.2K | — | — | 1.40M | 138.4K | 11.6K | 2.09M | 66.92% | ↗ |
| 16 | 2021 | W. Wilson Troutman Chief Financial Officer | 337.5K | — | — | 746.6K | 69.0K | 11.6K | 1.16M | 64.10% | ↗ |
| 17 | 2020 | Sean E. Brynjelsen President and Chief Executive Officer | 475.8K | — | — | 1.31M | 218.7K | 11.4K | 2.01M | 64.90% | ↗ |
| 18 | 2020 | W. Wilson Troutman Chief Financial Officer | 277.1K | — | — | 509.6K | 108.0K | 11.4K | 906.1K | 56.24% | ↗ |
| 19 | 2019 | Sean E. Brynjelsen President and Chief Executive Officer | 410.0K | — | — | 1.34M | 186.5K | 11.2K | 1.95M | 68.78% | ↗ |
| 20 | 2019 | W. Wilson Troutman Chief Financial Officer | 242.7K | — | — | 523.3K | 87.5K | 11.2K | 864.6K | 60.52% | ↗ |
| 21 | 2018 | Sean E. Brynjelsen President and Chief Executive Officer | 332.3K | — | — | — | 150.6K | 10.1K | 493.0K | 0.00% | ↗ |
| 22 | 2018 | W. Wilson Troutman Chief Financial Officer | 204.5K | — | — | — | 82.4K | 9.7K | 296.6K | 0.00% | ↗ |
| 23 | 2017 | Sean E. Brynjelsen President and Chief Executive Officer | 172.1K | — | 210.0K | 194.6K | 77.4K | — | 654.0K | 61.86% | ↗ |
| 24 | 2017 | W. Wilson Troutman Chief Financial Officer | 92.8K | — | — | 251.2K | 36.8K | — | 380.8K | 65.96% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Sean E. Brynjelsen | President, Chief Executive Officer & Director | 1M | male |
| James R. Gruber | Chief Financial Officer, Treasurer & Secretary | 740.5K | male |
| David Krempa | Chief Business Officer | 737.2K | male |
| Ipek Erdogan-Trinkaus | Chief Commercial Officer | 575.3K | female |
| Danka Radosavljevic | Executive Vice President of Operations | — | — |
| Judith Matthews | Executive Vice President of Accounting & Finance | — | female |
| Scott Grossenbach | Senior Vice President of Sales Operations | — | male |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
| Transaction Date | Disclosed | Representative | District | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2022-10-11 | 2022-12-01 | Thomas Suozzi | NY03 | — | Purchase | $15,001 - $50,000 | ↗ |
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ETON
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
